Aisling Capital Management LP Long-Term Concentrated

CIK: 0001766721 · Show all filings

Period: Q3 2023 (← Previous) (Next →)

Filing Date: Nov 13, 2023

Total Value ($000): $242,682 (100.0% shares, 0.0% debt)

Holdings (17)

BBIO BridgeBio Pharma Inc. (BBIO) 65.9%

Value ($000) $160,016 Shares 6,068,125 Est. Cost $40.43 Unrealized -29.8%

— Verona Pharma plc (VRNA) 7.5%

Value ($000) $18,180 Shares 1,115,352 Est. Cost $7.38 Unrealized —

SNDX Syndax Pharmaceuticals, Inc. (SNDX) 6.1%

Value ($000) $14,883 Shares 1,025,000 Est. Cost $10.24 Unrealized +84.7%

BMEA Biomea Fusion Inc (BMEA) 4.5%

Value ($000) $10,991 Shares 798,757 Est. Cost $17.65 Unrealized +2.1%

CMPS Compass Pathways Plc (CMPS) 2.9%

Value ($000) $7,137 Shares 964,500 Est. Cost $7.40 Unrealized —

GLUE Monte Rosa Therapeutics Inc (GLUE) 2.9%

Value ($000) $7,052 Shares 1,472,331 Est. Cost $20.37 Unrealized -68.4%

— Reneo Pharmaceuticals Inc (RPHM) 2.8%

Value ($000) $6,743 Shares 886,075 Est. Cost $9.33 Unrealized —

NUVB Nuvation Bio Inc. (NUVB) 1.4%

Value ($000) $3,405 Shares 2,541,009 Est. Cost $11.18 Unrealized -85.1%

ACRS Aclaris Theraputics Inc (ACRS) 1.2%

Value ($000) $2,976 Shares 434,455 Est. Cost $10.31 Unrealized -17.1%

— Spruce Biosciences, Inc. (SPRB) 1.1%

Value ($000) $2,724 Shares 1,205,511 Est. Cost $24.31 Unrealized —

— Poseida Therapeutics Inc. (PSTX) 1.0%

Value ($000) $2,483 Shares 1,043,267 Est. Cost $8.87 Unrealized —

— Elevation Oncology Inc (ELEV) 0.8%

Value ($000) $1,878 Shares 2,834,910 Est. Cost $13.57 Unrealized —

— Avrobio, Inc. (AVRO) 0.6%

Value ($000) $1,555 Shares 1,009,779 Est. Cost $16.72 Unrealized —

MRKR Marker Therapeutics, Inc. (MRKR) 0.6%

Value ($000) $1,427 Shares 314,286 Est. Cost $1.74 Unrealized +221.5%

SYRE Aeglea Biotherapeutics Inc (AGLE) 0.3%

Value ($000) $829 Shares 67,645 Est. Cost $13.22 Unrealized 0.0%

— Viracta Therapeutics Inc (VIRX) 0.1%

Value ($000) $300 Shares 288,571 Est. Cost $11.34 Unrealized —

— Atreca Inc. (BCEL) 0.0%

Value ($000) $101 Shares 387,653 Est. Cost $18.84 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
BBIO	BridgeBio Pharma Inc. (BBIO)	6,068,125	$160,016	65.9%	$40.43	-29.8%	COM	10806X102
—	Verona Pharma plc (VRNA)	1,115,352	$18,180	7.5%	$7.38	—	SPONSORED ADS	925050106
SNDX	Syndax Pharmaceuticals, Inc. (SNDX)	1,025,000	$14,883	6.1%	$10.24	+84.7%	COM	87164F105
BMEA	Biomea Fusion Inc (BMEA)	798,757	$10,991	4.5%	$17.65	+2.1%	COM	09077A106
CMPS	Compass Pathways Plc (CMPS)	964,500	$7,137	2.9%	$7.40	—	SPONSORED ADS	20451W101
GLUE	Monte Rosa Therapeutics Inc (GLUE)	1,472,331	$7,052	2.9%	$20.37	-68.4%	COM	61225M102
—	Reneo Pharmaceuticals Inc (RPHM)	886,075	$6,743	2.8%	$9.33	—	COM	75974E103
NUVB	Nuvation Bio Inc. (NUVB)	2,541,009	$3,405	1.4%	$11.18	-85.1%	COM CL A	67080N101
ACRS	Aclaris Theraputics Inc (ACRS)	434,455	$2,976	1.2%	$10.31	-17.1%	COM	00461U105
—	Spruce Biosciences, Inc. (SPRB)	1,205,511	$2,724	1.1%	$24.31	—	COM	85209E109
—	Poseida Therapeutics Inc. (PSTX)	1,043,267	$2,483	1.0%	$8.87	—	COM	73730P108
—	Elevation Oncology Inc (ELEV)	2,834,910	$1,878	0.8%	$13.57	—	COM	28623U101
—	Avrobio, Inc. (AVRO)	1,009,779	$1,555	0.6%	$16.72	—	COM	05455M100
MRKR	Marker Therapeutics, Inc. (MRKR)	314,286	$1,427	0.6%	$1.74	+221.5%	COM	57055L206
SYRE	Aeglea Biotherapeutics Inc (AGLE)	67,645	$829	0.3%	$13.22	0.0%	COM NEW	00773J202
—	Viracta Therapeutics Inc (VIRX)	288,571	$300	0.1%	$11.34	—	COM	92765F108
—	Atreca Inc. (BCEL)	387,653	$101	0.0%	$18.84	—	CL A COM	04965G109